Patent ID: 7199161

Claim:
A pharmaceutical combination, comprising: (A) at least one substituted bicyclo[3.3.1]nonane-2,4,9-triones compound of the general formula (I) in which: R 1 , R 2 , R 4 and R 5 , identical or different, are independently of one another one of the following groups: but with the proviso that if one of the radicals R 1 or R 2 or R 4 or R 5 is a benzoyl group, none of the other of these radicals is a benzoyl group; R 3 is a hydrogen atom; R 6 and R 7 are both in each case a methyl group or else in each case a hydrogen atom, and R 8 and R 9 are both in each case a methyl group or else in each case a hydrogen atom, but with the proviso that if R 6 and R 7 are methyl groups, R 8 and R 9 are hydrogen atoms, and that if R 8 and R 9 are methyl groups, R 6 and R 7 are hydrogen atoms; and/or its physiologically tolerated salts, hydrates, isomers, in particular stereoisomers, tautomers and structural isomers, derivatives, prodrugs and metabolites; and (B) at least one further chemotherapeutic agent, comprising a protein kinase inhibitor.